November 5 — Pfizer announced plans to invest $650 million in a new Manufacturing Technology Center at its Groton, Connecticut, research campus. The approximately 220,000-square-foot facility will manufacture clinical active pharmaceutical ingredients and finished drug products supporting clinical trials. Construction is expected to begin in the second quarter of 2027, with operations targeted for mid-2031. The project will consolidate existing manufacturing technology activities at the Groton campus. Manufacturing Dive
Source: Manufacturing Dive — Pfizer manufacturing investment
November 6 — Tesla CEO Elon Musk announced that Cybertruck production will wind down around mid-2027 at the company's Gigafactory Texas facility. Tesla plans to redirect manufacturing capacity toward its Cybercab autonomous vehicle program. The announcement follows lower-than-anticipated Cybertruck sales, with Kelley Blue Book estimating approximately 20,237 U.S. sales in 2025 and a further decline through September 2026. The decision represents a significant change in Tesla's vehicle production strategy. AP News
Source: Associated Press — Tesla Cybertruck production decision
November 6 — BWX Technologies announced plans to invest $714.5 million at its Jonesborough, Tennessee, facility to establish high-purity depleted uranium metal production for the U.S. Department of Energy's National Nuclear Security Administration. The project is expected to create 181 jobs, more than doubling the facility's existing workforce. The investment supports a previously awarded 10-year, $1.6 billion federal contract. Once operational, the plant is expected to be the only active U.S. facility capable of producing this specialized material for the government. TNECD
Source: Tennessee Department of Economic and Community Development — BWXT expansion
November 6 — Alphabet-owned Wing announced plans to invest up to $125 million over two years in domestic drone manufacturing, including a new 15,000-square-foot facility in Fort Worth, Texas. The operation is designed to produce tens of thousands of delivery aircraft annually and create up to 100 manufacturing jobs. Wing reports operating from more than 70 U.S. delivery sites and completing over one million domestic deliveries during 2026. The investment supports plans to expand its service to nearly 20 U.S. markets by 2027. Wing
Source: Wing — U.S. drone manufacturing expansion
November 6 — California-based Machina announced its selection for a U.S. Department of War program involving the development and qualification of low-cost unmanned aircraft structures. The project includes deployment of two pilot expeditionary robotic manufacturing facilities using Machina's RoboForming technology. The systems manufacture metal structures directly from digital designs without conventional forming dies or dedicated hard tooling. Initial development and qualification will take place at Machina's Los Angeles facilities before deployment of the distributed manufacturing systems. Machina
Source: Machina — Expeditionary robotic manufacturing program
November 3 — Swiss pharmaceutical contract manufacturer Lonza announced an agreement to acquire five U.S. manufacturing sites from Merck KGaA, Darmstadt, Germany. The transaction will increase Lonza's U.S. CDMO manufacturing footprint from four to nine facilities and add approximately 1,100 employees. The acquired operations include capabilities in bioconjugates, viral vectors, high-potency pharmaceutical intermediates and advanced drug-delivery technologies. Closing is expected in mid-2027, subject to customary conditions. Lonza
Source: Lonza — U.S. CDMO network acquisition
November 5 — Zipline announced $1.5 billion in new financing to expand domestic drone manufacturing and its nationwide delivery network. The company also announced a multi-year agreement with Walmart to establish 300 additional drone delivery sites. Specific locations and capacities for the planned manufacturing expansion have not yet been disclosed. Zipline
Source: Zipline — $1.5 billion financing and manufacturing expansion
November 5 — California-based Harbinger announced a $240 million Series D financing round supporting expansion of its electric commercial vehicle manufacturing and related technologies. The company manufactures Class 4–6 electric and plug-in hybrid commercial vehicle platforms and is developing products for energy storage, autonomous mobility and defense applications. Harbinger previously announced a 2,000-vehicle order from FedEx, with deliveries planned through 2027. Harbinger Motors
Source: Harbinger — Series D financing announcement
November 4 — Curtiss-Wright announced contracts exceeding $225 million from Bechtel Plant Machinery to supply advanced propulsion valves, pumps, and instrumentation and control systems. The equipment supports Virginia-class submarines, Columbia-class submarines and Ford-class aircraft carriers. The contracts cover components used in naval construction and fleet maintenance programs. Electro-Mechanical Systems
Source: Curtiss-Wright — U.S. Navy equipment contracts
November 4–6 — Ford's Changan joint venture disclosed the production design of the Lincoln Aviator EX8 plug-in hybrid SUV through China's regulatory approval process. The vehicle incorporates a 1.5-liter turbocharged gasoline engine, an electrified drivetrain and a LiDAR-based driver-assistance configuration. A formal public unveiling is expected later in November, with the Chinese market launch planned for 2027. The EX8 is not currently planned for the United States. Car and Driver
Source: Car and Driver — Lincoln Aviator EX8 introduction
November 6 — Callaway Golf announced a $15 million investment in a new 3D printing facility in Fort Worth, Texas. The operation will focus on titanium additive manufacturing, supporting complex component geometries and custom product development. The facility is expected to become operational in mid-2027 and begin supplying a portion of Callaway's U.S. product requirements in 2028. PR Newswire
Source: Callaway — U.S. additive manufacturing investment
November 6 — Onkos Surgical announced FDA 510(k) clearance expanding the use of its NanoCept antibacterial coating across additional titanium components in its ELEOS Limb Salvage System. The clearance covers components including proximal femurs, tibial baseplates and specialized stems. Onkos continues to develop the coating technology and its manufacturing capabilities at its innovation center in Bridgewater, New Jersey. The technology is intended to reduce bacterial contamination before implantation; a reduction in clinical infection rates has not been established in human trials. PR Newswire
Source: Onkos Surgical — FDA clearance announcement
November 3 — Beckman Coulter Diagnostics announced FDA clearance for its Access MeMed BV blood test, which helps distinguish bacterial from viral infections by measuring immune-response markers. The test operates on the company's existing DxI 9000 and Access 2 immunoassay analyzers, with results available in as little as 15 minutes on the DxI 9000. The clearance covers adult and pediatric patients, including children as young as 90 days old. Beckman Coulter Newsroom
Source: Beckman Coulter — Access MeMed BV clearance
November 3 — Danaher subsidiary Cepheid announced FDA clearance for its Xpert Hemorrhagic Fever Panel, a molecular diagnostic test capable of detecting several high-consequence viral pathogens from one sample. The panel includes Ebola, Marburg, Lassa and Crimean-Congo hemorrhagic fever viruses and produces results in approximately 61 minutes using Cepheid's GeneXpert Dx system. The clearance expands the company's molecular diagnostic portfolio for infectious-disease testing. PR Newswire
Source: Cepheid — Hemorrhagic Fever Panel FDA clearance
November 2 — The Federal Register published a presidential proclamation signed October 28 concerning imports of robotics, industrial machinery and related components under Section 232 of the Trade Expansion Act.
The proclamation follows a Department of Commerce investigation that identified national-security concerns involving dependence on imported industrial automation equipment and manufacturing machinery. It directs the Commerce Department and U.S. Trade Representative to pursue negotiations with trading partners and provide an update within 180 days.
The proclamation identifies potential future measures including tariffs, quotas, import fees and incentives for domestic manufacturing. It does not itself impose new tariffs on industrial robots or machinery.
The policy covers equipment used extensively in automotive, aerospace, defense, electronics and other manufacturing sectors. GovInfo
Source: Federal Register — Proclamation 11077, robotics and industrial machinery imports
November 6 — The FDA's Center for Devices and Radiological Health released a discussion paper examining benefit-risk considerations for medical robotic systems incorporating autonomous operation or remote teleoperation.
The document addresses diagnostic, therapeutic and rehabilitative devices, including robotic surgical equipment and systems used to position or control medical instruments. Topics include terminology, risks associated with autonomy, remote operation and possible risk-mitigation approaches.
The agency is requesting public feedback from medical-device manufacturers, regulatory professionals, healthcare providers and other stakeholders by January 5, 2027.
The document is intended to inform discussion and is not draft or final regulatory guidance. It does not establish new FDA approval requirements. U.S. Food and Drug Administration
Source: FDA — Autonomous and remote medical robotics discussion paper
November 5 — Agility Robotics completed its business combination with Churchill Capital Corp XI and began trading on Nasdaq under the symbol AGLT. The transaction and associated financing provided approximately $465 million in gross capital before expenses.
Agility reported more than $300 million in committed multi-year orders for its next-generation Digit 5 humanoid robot, subject to contractual and product milestones. The company also reported approximately 65,000 hours of real-world robot operation, including deployments with GXO, Schaeffler and Toyota Motor Manufacturing Canada.
Its 70,000-square-foot RoboFab facility in Salem, Oregon, is designed for annual manufacturing capacity of up to 10,000 robots, although actual production volumes have not reached that level.
The company expects early customer access to Digit 5 during the first half of 2027, with general availability targeted for the end of that year. Agility Robotics Investors
Source: Agility Robotics — Public listing and commercial deployment update
November 2 — The Institute for Supply Management reported that its Manufacturing Purchasing Managers' Index increased to 55.5 in October, up from 54.5 in September. Readings above 50 indicate expansion, making October the tenth consecutive month of manufacturing growth.
All five components contributing directly to the headline PMI were in expansion territory. The Production Index increased to 59.0, its highest level since November 2021, while new orders and employment also expanded.
Among the largest manufacturing industries, machinery, computer and electronic products, transportation equipment and chemicals reported growth.
The survey also documented continued input-cost pressures and supply constraints, particularly for materials and equipment supporting AI infrastructure and other industrial investment. Institute for Supply Management
Source: Institute for Supply Management — October 2026 Manufacturing PMI report
November 5 — Texas-based Applied Optoelectronics reported continued expansion of its manufacturing operations for 800G and 1.6-terabit optical transceivers used in AI data centers and high-performance computing networks.
The company said its installed manufacturing equipment capacity was approaching 330,000 units per month, with plans to increase installed capacity to more than 500,000 units monthly by the end of 2026. Its longer-term target is manufacturing capacity exceeding one million units monthly by the end of 2027.
Applied Optoelectronics also disclosed that its U.S. expansion plans were taking longer than anticipated because of delays in obtaining electrical power and other construction-related challenges.
The company reported a multi-year strategic agreement with a major hyperscale data-center customer and said it would continue investing in manufacturing capacity for high-bandwidth optical networking products. PR Newswire
Source: Applied Optoelectronics — Third-quarter 2026 results and manufacturing outlook